YD Bio Limited Ordinary Shares
YDES · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,215 | -$3,368 | $418 | $2,190 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $89 | -$135 | $16 | $226 |
| Other Non-Cash | $1,827 | $3,012 | -$799 | -$2,438 |
| Operating Cash Flow | -$298 | -$490 | -$366 | -$22 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$27 | -$69 | -$94 | -$63 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $584 | $7,353 | $262 | $0 |
| Investing Cash Flow | $557 | $7,284 | $168 | -$63 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $331 | $459 | $299 | $44 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$584 | -$7,353 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$253 | -$6,895 | $299 | $44 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6 | -$101 | $102 | -$40 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $102 | $0 | $40 |
| End Cash | $6 | $0 | $102 | $0 |
| Free Cash Flow | -$298 | -$490 | -$366 | -$22 |